145 related articles for article (PubMed ID: 27644630)
1. Lack of Association between Serum Adiponectin/Leptin Levels and Medullary Thyroid Cancer.
Abooshahab R; Yaghmaei P; Ghadaksaz HG; Hedayati M
Asian Pac J Cancer Prev; 2016; 17(8):3861-4. PubMed ID: 27644630
[TBL] [Abstract][Full Text] [Related]
2. Serum level of dipeptidyl peptidase-4 as a potential biomarker for medullary thyroid cancer.
Abooshahab R; Niyazi E; Yaghmaie P; Ghadaksaz HG; Hedayati M
Exp Oncol; 2018 Dec; 40(4):299-302. PubMed ID: 30593752
[TBL] [Abstract][Full Text] [Related]
3. Medullary Thyroid Carcinoma--Circulating Status of Vaspin and Retinol Binding Protein-4 in Iranian Patients.
Jabbari S; Hedayati M; Yaghmaei P; Parivar K
Asian Pac J Cancer Prev; 2015; 16(15):6507-12. PubMed ID: 26434866
[TBL] [Abstract][Full Text] [Related]
4. Imbalance in leptin-adiponectin levels and leptin receptor expression as chief contributors to triple negative breast cancer progression in Northeast India.
Sultana R; Kataki AC; Borthakur BB; Basumatary TK; Bose S
Gene; 2017 Jul; 621():51-58. PubMed ID: 28414093
[TBL] [Abstract][Full Text] [Related]
5. Effects of thyroid hormones on serum levels of adipokines as studied in patients with differentiated thyroid carcinoma during thyroxine withdrawal.
Botella-Carretero JI; Alvarez-Blasco F; Sancho J; Escobar-Morreale HF
Thyroid; 2006 Apr; 16(4):397-402. PubMed ID: 16646687
[TBL] [Abstract][Full Text] [Related]
6. Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: The EPIC study.
Dossus L; Franceschi S; Biessy C; Navionis AS; Travis RC; Weiderpass E; Scalbert A; Romieu I; Tjønneland A; Olsen A; Overvad K; Boutron-Ruault MC; Bonnet F; Fournier A; Fortner RT; Kaaks R; Aleksandrova K; Trichopoulou A; La Vecchia C; Peppa E; Tumino R; Panico S; Palli D; Agnoli C; Vineis P; Bueno-de-Mesquita HBA; Peeters PH; Skeie G; Zamora-Ros R; Chirlaque MD; Ardanaz E; Sánchez MJ; Ramón Quirós J; Dorronsoro M; Sandström M; Nilsson LM; Schmidt JA; Khaw KT; Tsilidis KK; Aune D; Riboli E; Rinaldi S
Int J Cancer; 2018 Apr; 142(7):1332-1342. PubMed ID: 29168186
[TBL] [Abstract][Full Text] [Related]
7. Relationship between thyroid volume and iodine, leptin, and adiponectin in obese women before and after weight loss.
Eray E; Sari F; Ozdem S; Sari R
Med Princ Pract; 2011; 20(1):43-6. PubMed ID: 21160213
[TBL] [Abstract][Full Text] [Related]
8. Adipokines, endothelial dysfunction and nutritional status in peritoneal dialysis patients.
Małgorzewicz S; Lichodziejewska-Niemierko M; Aleksandrowicz-Wrona E; Świetlik D; Rutkowski B; Łysiak-Szydłowska W
Scand J Urol Nephrol; 2010 Dec; 44(6):445-51. PubMed ID: 20624111
[TBL] [Abstract][Full Text] [Related]
9. Negative predictive value of procalcitonin in medullary thyroid carcinoma.
Lim SK; Guéchot J; Vaubourdolle M
Ann Biol Clin (Paris); 2016; 74(2):213-8. PubMed ID: 26806393
[TBL] [Abstract][Full Text] [Related]
10. Roles of adiponectin and leptin as diagnostic markers in pancreatic cancer.
Kadri Colakoglu M; Bostanci EB; Ozdemir Y; Dalgic T; Aksoy E; Ozer I; Ozogul Y; Oter V
Bratisl Lek Listy; 2017; 118(7):394-398. PubMed ID: 28766348
[TBL] [Abstract][Full Text] [Related]
11. Resistin, visfatin, adiponectin, and leptin: risk of breast cancer in pre- and postmenopausal saudi females and their possible diagnostic and predictive implications as novel biomarkers.
Assiri AM; Kamel HF; Hassanien MF
Dis Markers; 2015; 2015():253519. PubMed ID: 25838618
[TBL] [Abstract][Full Text] [Related]
12. Serum adiponectin and leptin levels are useful markers for prostate cancer screening after adjustments for age, obesity-related factors, and prostate volume.
Nishimura K; Soda T; Nakazawa S; Yamanaka K; Hirai T; Kishikawa H; Ichikawa Y
Minerva Urol Nefrol; 2012 Sep; 64(3):199-208. PubMed ID: 22971685
[TBL] [Abstract][Full Text] [Related]
13. Leptin and adiponectin dynamics at patients with rectal neoplasm - Gender differences.
Florescu A; Branisteanu D; Bilha S; Scripcariu D; Florescu I; Scripcariu V; Dimofte G; Grigoras I
PLoS One; 2019; 14(8):e0212471. PubMed ID: 31425509
[TBL] [Abstract][Full Text] [Related]
14. Impact of serum adiponectin and leptin levels in acute leukemia.
Aref S; Ibrahim L; Azmy E; Al Ashary R
Hematology; 2013 Jul; 18(4):198-203. PubMed ID: 23321463
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum adiponectin level in patients with Mycobacterium avium-intracellulare complex pulmonary disease.
Tasaka S; Hasegawa N; Nishimura T; Yamasawa W; Kamata H; Shinoda H; Kimizuka Y; Fujiwara H; Hirose H; Ishizaka A
Respiration; 2010; 79(5):383-7. PubMed ID: 19641295
[TBL] [Abstract][Full Text] [Related]
16. Utilizing the circulating tumor markers in diagnosis and management of medullary thyroid cancer.
Zarkesh M; Arab N; Tavangar SM; Nozhat Z; Fanaei SM; Hedayati M
Pathol Res Pract; 2022 Jan; 229():153694. PubMed ID: 34929598
[TBL] [Abstract][Full Text] [Related]
17. Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome.
Dalamaga M; Karmaniolas K; Chamberland J; Nikolaidou A; Lekka A; Dionyssiou-Asteriou A; Mantzoros CS
Metabolism; 2013 Dec; 62(12):1830-9. PubMed ID: 24140093
[TBL] [Abstract][Full Text] [Related]
18. Serum adipokine levels in patients with sarcoidosis.
Kobak S; Semiz H; Akyildiz M; Gokduman A; Atabay T; Vural H
Clin Rheumatol; 2020 Jul; 39(7):2121-2125. PubMed ID: 32060810
[TBL] [Abstract][Full Text] [Related]
19. Adipocytokines and breast cancer risk.
Hou WK; Xu YX; Yu T; Zhang L; Zhang WW; Fu CL; Sun Y; Wu Q; Chen L
Chin Med J (Engl); 2007 Sep; 120(18):1592-6. PubMed ID: 17908478
[TBL] [Abstract][Full Text] [Related]
20. SERUM ADIPONECTIN AND INSULIN-LIKE GROWTH FACTOR 1 IN PREDOMINANTLY FEMALE PATIENTS WITH THYROID CANCER: ASSOCIATION WITH THE HISTOLOGIC CHARACTERISTICS OF THE TUMOR.
Pazaitou-Panayiotou K; Panagiotou G; Polyzos SA; Mantzoros CS
Endocr Pract; 2016 Jan; 22(1):68-75. PubMed ID: 26484409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
